Wipro Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 30, 2025, 11:58 am

Quick Insight

Wipro Ltd, a prominent player in the IT Consulting & Software industry, currently trades at a price of 252 with a market capitalization of 2,64,209 Cr. The company boasts a healthy P/E ratio of 19.6 and robust returns with an ROE of 16.6% and an ROCE of 19.5%. Operating at an OPM of 19%, Wipro has recorded a Net Profit of 13,218 Cr, supported by substantial reserves of 80,736 Cr. However, it is essential to note the significant level of borrowings amounting to ₹19,204 Cr, reflecting a CCC of 48 days. With a P/BV of 3.33x and an ICR of 14.83x, investors should carefully monitor the company's leverage and efficiency ratios to gauge its financial health amidst its growth trajectory.

Competitors of Wipro Ltd

All Competitor Stocks of Wipro Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:10 am

Below is a detailed analysis of the quarterly data for Wipro Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 22,135.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22,504.00 Cr. (Mar 2025) to 22,135.00 Cr., marking a decrease of 369.00 Cr..
• For Expenses, as of Jun 2025, the value is 17,902.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,880.00 Cr. (Mar 2025) to 17,902.00 Cr., marking an increase of 22.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 4,233.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,624.00 Cr. (Mar 2025) to 4,233.00 Cr., marking a decrease of 391.00 Cr..
• For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 19.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 1,072.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,217.00 Cr. (Mar 2025) to 1,072.00 Cr., marking a decrease of 145.00 Cr..
• For Interest, as of Jun 2025, the value is 361.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 377.00 Cr. (Mar 2025) to 361.00 Cr., marking a decrease of 16.00 Cr..
• For Depreciation, as of Jun 2025, the value is 686.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 722.00 Cr. (Mar 2025) to 686.00 Cr., marking a decrease of 36.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 4,258.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,743.00 Cr. (Mar 2025) to 4,258.00 Cr., marking a decrease of 485.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 22.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 3,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,588.00 Cr. (Mar 2025) to 3,336.00 Cr., marking a decrease of 252.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.18. The value appears to be declining and may need further review. It has decreased from 3.41 (Mar 2025) to 3.18, marking a decrease of 0.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:43 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:03 pm

Below is a detailed analysis of the balance sheet data for Wipro Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 2,094.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,045.00 Cr. (Mar 2024) to 2,094.00 Cr., marking an increase of 1,049.00 Cr..
• For Reserves, as of Mar 2025, the value is 80,736.00 Cr.. The value appears strong and on an upward trend. It has increased from 73,943.00 Cr. (Mar 2024) to 80,736.00 Cr., marking an increase of 6,793.00 Cr..
• For Borrowings, as of Mar 2025, the value is 19,204.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 16,465.00 Cr. (Mar 2024) to 19,204.00 Cr., marking an increase of 2,739.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 26,362.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23,611.00 Cr. (Mar 2024) to 26,362.00 Cr., marking an increase of 2,751.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 128,396.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 115,064.00 Cr. (Mar 2024) to 128,396.00 Cr., marking an increase of 13,332.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 45,654.00 Cr.. The value appears strong and on an upward trend. It has increased from 44,083.00 Cr. (Mar 2024) to 45,654.00 Cr., marking an increase of 1,571.00 Cr..
• For CWIP, as of Mar 2025, the value is 221.00 Cr.. The value appears to be declining and may need further review. It has decreased from 748.00 Cr. (Mar 2024) to 221.00 Cr., marking a decrease of 527.00 Cr..
• For Investments, as of Mar 2025, the value is 43,926.00 Cr.. The value appears strong and on an upward trend. It has increased from 33,384.00 Cr. (Mar 2024) to 43,926.00 Cr., marking an increase of 10,542.00 Cr..
• For Other Assets, as of Mar 2025, the value is 38,595.00 Cr.. The value appears strong and on an upward trend. It has increased from 36,848.00 Cr. (Mar 2024) to 38,595.00 Cr., marking an increase of 1,747.00 Cr..
• For Total Assets, as of Mar 2025, the value is 128,396.00 Cr.. The value appears strong and on an upward trend. It has increased from 115,064.00 Cr. (Mar 2024) to 128,396.00 Cr., marking an increase of 13,332.00 Cr..

Notably, the Reserves (80,736.00 Cr.) exceed the Borrowings (19,204.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Wipro Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 12.56. This value is within the healthy range. It has decreased from 20.89 (Mar 24) to 12.56, marking a decrease of 8.33.
• For Diluted EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has decreased from 20.82 (Mar 24) to 12.52, marking a decrease of 8.30.
• For Cash EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has decreased from 27.83 (Mar 24) to 15.42, marking a decrease of 12.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 78.65. It has decreased from 142.90 (Mar 24) to 78.65, marking a decrease of 64.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 78.65. It has decreased from 142.90 (Mar 24) to 78.65, marking a decrease of 64.25.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.07. It has decreased from 171.79 (Mar 24) to 85.07, marking a decrease of 86.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 20.92. This value is within the healthy range. It has decreased from 37.14 (Mar 24) to 20.92, marking a decrease of 16.22.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.09. This value is within the healthy range. It has decreased from 30.62 (Mar 24) to 18.09, marking a decrease of 12.53.
• For PBT / Share (Rs.), as of Mar 25, the value is 16.68. This value is within the healthy range. It has decreased from 28.22 (Mar 24) to 16.68, marking a decrease of 11.54.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.60. This value is within the healthy range. It has decreased from 21.31 (Mar 24) to 12.60, marking a decrease of 8.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.54. This value is within the healthy range. It has decreased from 21.14 (Mar 24) to 12.54, marking a decrease of 8.60.
• For PBDIT Margin (%), as of Mar 25, the value is 24.58. This value is within the healthy range. It has increased from 21.62 (Mar 24) to 24.58, marking an increase of 2.96.
• For PBIT Margin (%), as of Mar 25, the value is 21.26. This value exceeds the healthy maximum of 20. It has increased from 17.82 (Mar 24) to 21.26, marking an increase of 3.44.
• For PBT Margin (%), as of Mar 25, the value is 19.61. This value is within the healthy range. It has increased from 16.42 (Mar 24) to 19.61, marking an increase of 3.19.
• For Net Profit Margin (%), as of Mar 25, the value is 14.80. This value exceeds the healthy maximum of 10. It has increased from 12.40 (Mar 24) to 14.80, marking an increase of 2.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has increased from 12.30 (Mar 24) to 14.74, marking an increase of 2.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.94. This value is within the healthy range. It has increased from 14.81 (Mar 24) to 15.94, marking an increase of 1.13.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.03. This value is within the healthy range. It has increased from 17.86 (Mar 24) to 19.03, marking an increase of 1.17.
• For Return On Assets (%), as of Mar 25, the value is 10.24. This value is within the healthy range. It has increased from 9.62 (Mar 24) to 10.24, marking an increase of 0.62.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 0.19, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.77 (Mar 24) to 0.73, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 2.72. This value is within the healthy range. It has increased from 2.58 (Mar 24) to 2.72, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 2.71. This value exceeds the healthy maximum of 2. It has increased from 2.57 (Mar 24) to 2.71, marking an increase of 0.14.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.72 (Mar 24) to 0.00, marking a decrease of 4.72.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.61 (Mar 24) to 0.00, marking a decrease of 3.61.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.28 (Mar 24) to 0.00, marking a decrease of 95.28.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.39 (Mar 24) to 0.00, marking a decrease of 96.39.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.83. This value is within the healthy range. It has decreased from 15.46 (Mar 24) to 14.83, marking a decrease of 0.63.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.93. This value is within the healthy range. It has increased from 9.87 (Mar 24) to 9.93, marking an increase of 0.06.
• For Enterprise Value (Cr.), as of Mar 25, the value is 278,669.22. It has increased from 255,411.43 (Mar 24) to 278,669.22, marking an increase of 23,257.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.13. This value exceeds the healthy maximum of 3. It has increased from 2.85 (Mar 24) to 3.13, marking an increase of 0.28.
• For EV / EBITDA (X), as of Mar 25, the value is 12.72. This value is within the healthy range. It has decreased from 13.16 (Mar 24) to 12.72, marking a decrease of 0.44.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has increased from 2.79 (Mar 24) to 3.08, marking an increase of 0.29.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 95.27 (Mar 24) to 0.00, marking a decrease of 95.27.
• For Price / BV (X), as of Mar 25, the value is 3.33. This value exceeds the healthy maximum of 3. It has decreased from 3.37 (Mar 24) to 3.33, marking a decrease of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has increased from 2.79 (Mar 24) to 3.08, marking an increase of 0.29.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness